(19)
(11) EP 4 816 410 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817215.7

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
A61K 40/42(2025.01)
 A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/3092; A61K 39/00117; C07K 2317/34; C07K 2317/33; A61K 39/001172; A61K 2039/575; A61K 2039/545; A61K 2039/54; A61K 40/4259
(86) International application number:
PCT/EP2024/083802
(87) International publication number:
WO 2025/114381 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 EP 23212281

(71) Applicants:
  • Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
    69120 Heidelberg (DE)
  • Panosome GmbH
    69123 Heidelberg (DE)

(72) Inventors:
  • VERDI, Joseph
    69120 Heidelberg (DE)
  • PAPAVASILIOU-STEBBINS, Fotini
    69120 Heidelberg (DE)
  • CHANDRA, Monica
    69123 Heidelberg (DE)
  • STEBBINS, Charles Erec
    69120 Heidelberg (DE)
  • KRUSE, Sebastian
    69123 Heidelberg (DE)
  • URBAN, Katharina
    69123 Heidelberg (DE)
  • GKEKA, Anastasia
    69123 Heidelberg (DE)
  • VLACHOU-EFSTATHIOU, Paraskevi Maria
    69123 Heidelberg (DE)
  • SIDIROPOULOU, Eirini
    69120 Heidelberg (DE)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) MUC1 ANTIBODIES AND USES THEREOF